```html

Jaundice in Newborns: A Complete Guide for Parents

What is Jaundice of newborns?

Jaundice is a yellow discoloration of the skin, sclera (the white part of the eyes), and sometimes the mucous membranes caused by an excess of bilirubin in the bloodstream. In newborns, jaundice is very common—affecting up to 60 % of term infants and 80 % of pre‑term infants in the first week of life. The condition is usually benign and resolves spontaneously, but very high bilirubin levels can be dangerous because bilirubin can cross the immature blood‑brain barrier and cause permanent neurological damage (kernicterus).

Newborn jaundice is classified by timing:

• Physiologic jaundice – appears 2–3 days after birth, peaks around day 5, and resolves within 1–2 weeks.
• Pathologic jaundice – appears within the first 24 hours, rises faster than 0.2 mg/dL per hour, or persists beyond 2 weeks.

Understanding why the bilirubin level is high helps clinicians decide whether simple observation, phototherapy, or more intensive treatment is needed.

Common Causes

The following conditions account for the majority of newborn jaundice cases. Some are normal developmental processes, while others signal an underlying disorder.

• Physiologic immaturity of the liver – Newborn livers lack full enzyme activity to conjugate bilirubin.
• Breast‑milk jaundice – Occurs after the first week; certain substances in breast milk increase enterohepatic circulation of bilirubin.
• Breast‑feeding failure jaundice – Inadequate milk intake leads to dehydration and reduced bilirubin excretion.
• Hemolytic disease of the newborn (HDN) – Maternal‑fetal blood group incompatibility (e.g., Rh or ABO) causes rapid red‑cell breakdown.
• Cephalohematoma or bruising – Internal bleeding under the scalp releases a large amount of hemoglobin, increasing bilirubin.
• G6PD deficiency – An inherited enzyme defect that predisposes red cells to hemolysis, especially after certain foods or drugs.
• Congenital infections (TORCH) – Toxoplasmosis, Rubella, Cytomegalovirus, Herpes, and others can impair bilirubin metabolism.
• Neonatal sepsis – Inflammation and liver dysfunction raise bilirubin levels.
• Metabolic disorders – Examples include hypothyroidism, galactosemia, and inborn errors of bilirubin conjugation (e.g., Crigler‑Najjar syndrome).
• Drug‑induced jaundice – Certain antibiotics (e.g., sulfonamides) or maternal medications passed through breast milk can interfere with hepatic conjugation.

Associated Symptoms

While the yellow tint is the hallmark sign, other findings often accompany newborn jaundice:

• Lethargy or excessive sleepiness
• Poor feeding or reduced weight gain
• High‑pitched crying
• Dark, tea‑colored urine (indicative of conjugated bilirubin)
• Pale, chalky stools (suggesting decreased bile flow)
• Abdominal distention (possible liver enlargement)
• Signs of hemolysis: pallor, rapid heartbeat, enlarged spleen

When to See a Doctor

All newborns with visible jaundice should be evaluated, but urgent care is required if any of the following occur:

• Jaundice appearing within the first 24 hours of life.
• Rapid progression—yellowing spreading from the head to the chest, abdomen, and limbs within a few hours.
• Skin or eyes appear bright yellow (bilirubin likely > 12 mg/dL in term infants).
• Feeding difficulties, vomiting, or a drop in weight.
• Lethargy, high‑pitched cry, or poor responsiveness.
• Signs of dehydration: dry mouth, few wet diapers (< 6 per day).
• Any family history of blood‑type incompatibility, G6PD deficiency, or metabolic disease.

Prompt evaluation prevents complications and helps determine if phototherapy or exchange transfusion is needed.

Diagnosis

Healthcare providers use a combination of visual assessment and laboratory tests.

1. Physical exam – The clinician checks the level of skin discoloration (head, chest, abdomen, limbs) and looks for scleral staining.
2. Transcutaneous bilirubinometer (TcB) – A painless device that estimates bilirubin through the skin; useful for screening.
3. Serum total bilirubin (TSB) – Blood draw to obtain an exact bilirubin concentration. It also separates direct (conjugated) from indirect (unconjugated) bilirubin.
4. Blood type & Coombs test – Determines maternal‑infant ABO/Rh incompatibility and whether antibodies are attached to newborn red cells.
5. Complete blood count (CBC) & reticulocyte count – Assesses for hemolysis.
6. Urinalysis & stool color – Helps differentiate conjugated vs. unconjugated jaundice.
7. Additional labs if indicated – G6PD screening, thyroid function tests, liver enzymes, or infectious work‑up (TORCH titers).

Results are plotted on a bilirubin nomogram (the Bhutani chart) that incorporates the infant’s age in hours, gestational age, and risk factors to guide treatment thresholds.

Treatment Options

Management aims to keep bilirubin below neurotoxic levels while treating the underlying cause.

Phototherapy

• Standard of care for most newborns with a bilirubin level above the treatment threshold.
• Blue‑green light (≈460 nm) converts bilirubin into water‑soluble isomers that can be excreted without conjugation.
• Types: conventional overhead lamps, fiber‑optic blankets, or LED biliblankets.
• Typical duration: 12–48 hours, reassessed every 4–6 hours.

Exchange Transfusion

• Reserved for severe hyperbilirubinemia (usually > 20 mg/dL in term infants) or when phototherapy fails.
• Partial removal of the infant’s blood and replacement with donor blood to rapidly lower bilirubin.
• Performed in a neonatal intensive care unit (NICU) by experienced staff.

Intravenous Immunoglobulin (IVIG)

• Used for hemolytic disease due to ABO or Rh incompatibility when rapid hemolysis is present.
• IVIG blocks Fc receptors, reducing further red‑cell destruction.

Supportive & Home Measures

• Frequent feeding – 8–12 times per day encourages stooling, the main route for bilirubin elimination.
• Adequate hydration – Ensures urine output ≥ 1 mL/kg/hr.
• Monitor weight – A loss > 5 % of birth weight warrants medical review.
• Continue breastfeeding – Except in rare cases where temporary interruption is recommended to lower bilirubin while maintaining milk supply.
• Sunlight exposure – Brief, indirect sunlight on the baby’s skin (10‑15 minutes, a few times per day) can modestly lower bilirubin, but it is not a substitute for phototherapy.

Prevention Tips

While physiologic jaundice cannot be completely avoided, several strategies reduce the risk or severity of pathologic jaundice:

• Start breastfeeding within the first hour after birth and ensure latch is effective.
• Encourage skin‑to‑skin contact (kangaroo care) to stimulate feeding cues.
>
• Track diaper output: ≥ 6 wet diapers and ≥ 3 yellow stools per day in the first week.
• For at‑risk mothers (e.g., O‑negative, previous infant with HDN), receive appropriate prenatal antibody screening and intra‑partum Rh immunoglobulin.
• Check newborn bilirubin levels before discharge, especially for pre‑term infants, twins, or those with bruising/hemolysis.
• Avoid early use of drugs that displace bilirubin from albumin (e.g., sulfonamides) unless medically necessary.
• Educate caregivers on early signs of jaundice and the importance of follow‑up appointments.

Emergency Warning Signs

Key Take‑aways

• Jaundice is common in newborns, but bilirubin levels that rise too quickly can be dangerous.
• Early identification—especially within the first 24 hours—allows timely treatment with phototherapy or, in rare cases, exchange transfusion.
• Frequent feeding, proper breastfeeding techniques, and routine bilirubin checks are the most effective preventive measures.
• Never hesitate to seek emergency care if a newborn becomes unusually sleepy, stops feeding, or develops severe yellowing.

For further reading, consult reputable sources such as the Mayo Clinic, CDC, and the National Institutes of Health.

```